Search Results - "Cervesi, Julie"

NSCLC Immunotherapy Efficacy and Antibiotic Use: A Systematic Review and Meta-Analysis by Lurienne, Lise, Cervesi, Julie, Duhalde, Lola, de Gunzburg, Jean, Andremont, Antoine, Zalcman, Gérard, Buffet, Renaud, Bandinelli, Pierre-Alain

“…Immune checkpoint inhibitors (ICIs) have dramatically improved patient outcomes in a variety of tumor types, but with variable efficacy. Recent research has…”
Get more information

Spare and repair the gut microbiota from antibiotic-induced dysbiosis: state-of-the-art by Andremont, Antoine, Cervesi, Julie, Bandinelli, Pierre-Alain, Vitry, Fabien, de Gunzburg, Jean

“…•The gut microbiota is regarded nowadays as a key component for human health.•Dysbiosis is an unrecognized disease whose consequences just begin to be…”
Get full text

A systematic review and meta-analysis evaluating the impact of antibiotic use on the clinical outcomes of cancer patients treated with immune checkpoint inhibitors by Crespin, Athéna, Le Bescop, Clément, de Gunzburg, Jean, Vitry, Fabien, Zalcman, Gérard, Cervesi, Julie, Bandinelli, Pierre-Alain

“…Immune checkpoint inhibitors (ICIs) have considerably improved patient outcomes in various cancer types, but their efficacy remains poorly predictable among…”
Get full text

278 Systematic review and meta-analysis evaluating the impact of antibiotic use on clinical outcomes of non-small-cell lung cancer patients treated with immune checkpoint inhibitors by Crespin, Athéna, Bandinelli, Pierre-Alain, Bescop, Clément Le, Buffet, Renaud, Gunzburg, Jean De, Vitry, Fabien, Zalcman, Gérard, Cervesi, Julie

“…BackgroundIn recent years, the gut microbiome has increasingly emerged as influencing the response to immune checkpoint inhibitors (ICIs).1–3 Antibiotic (ABX)…”
Get full text

Prognostic Associations of Concomitant Antibiotic Use in Patients with Advanced NSCLC Treated with Atezolizumab: Sensitivity Analysis of a Pooled Investigation of Five Randomised Control Trials by Manning-Bennett, Arkady T, Cervesi, Julie, Bandinelli, Pierre-Alain, Sorich, Michael J, Hopkins, Ashley M

“…Immune checkpoint inhibitors (ICIs) have been a significant milestone for the treatment of advanced non-small cell lung cancer (NSCLC). However, the efficacy…”
Get full text

671 Update of a systematic review and meta-analysis studying the association between antibiotic use and clinical outcomes of non-small-cell lung cancer patients treated with immune checkpoint inhibitors by Bandinelli, Pierre-Alain, Cervesi, Julie, Bescop, Clément Le, Buffet, Renaud, Gunzburg, Jean De, Zalcman, Gérard

“…BackgroundImmune checkpoint inhibitors (ICIs) have been shown to improve patients‘ clinical outcomes in a variety of cancers, but with variable efficacy. Prior…”
Get full text

Systematic review and meta-analysis evaluating the impact of antibiotic use on the clinical outcomes of patients with cancer treated with immune checkpoint inhibitors by Zalcman, Gerard, Crespin, Athéna, Cervesi, Julie, Le Bescop, Clément, Buffet, Renaud, de Gunzburg, Jean, Vitry, Fabien, Bandinelli, Pierre-Alain

“…2585 Background: In recent years, the gut microbiome has increasingly emerged as influencing the response to immune checkpoint inhibitors (ICIs) and antibiotic…”
Get full text